FDA approval for the first generation of sensor
27 January 2022
Sunrise V1 has received FDA De Novo approval in the U.S. This is a major milestones for the company and the first step to making the solution available to millions of people suffering from sleep apnea in the US.
Laurent Martinot said this is an exciting time for Sunrise.